Efficacy and Safety of Venetoclax Plus Hypomethylating Agents in Relapsed/refractory Acute Myeloid Leukemia: a Multicenter Real-Life Experience
FRONTIERS IN ONCOLOGY(2024)
Key words
acute myeloid leukemia,venetoclax,hypomethylating agents,azacitidine,decitabine,relapsed/refractory acute myeloid leukemia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined